About Index Trending news
Lists
Pricing
Immunocore

Immunocore

Immunocore

A world-leading biotechnologycompany with a highly innovative immune-oncology T cell receptor platform technology

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital (Series B)
$40,000,000
Bill & Melinda Gates Foundation, Bill & Melinda Gates Foundation
Venture capital
$320,000,000
Employees

Team size

50+
Locations
HQ

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Immunocore makes some noise.